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T-lymphocyte populations comprise functionally different cell subsets which carry 
distinctive Ly surface components (1). The contribution of these T-cell subsets to the 
cytotoxic T-lymphocyte (CTL) 1 response against  alloantigens  has been extensively 
studied. In adult life, T  cells which express the Thy 1  + Lyl-2÷3  + surface phenotype 
(Ly23  cells)  bind  and  react  to  foreign  H-2K/D  region  products  (2,  3)  and  are 
responsible  for alloreactive  prekiller  and  killer-effector activity.  The  generation  of 
cytotoxieity by limiting numbers of Ly23 prekiller cells is amplified by cells of the 
Lyl set, which are selectively stimulated  by products of the I  region of the major 
histocompatibility complex (MHC) (4). 
The frequency of prekiller cells in the Ly23 population capable of developing into 
cytotoxic effector cells after stimulation across a single MHC haplotype difference has 
been estimated at approximately  1-3%  (5-7). This inordinately large proportion of 
alloreactive prekiller cells is in accord with the high frequency of cells that mount a 
proliferative response after stimulation by cells differing at a single MHC haplotype 
(8). Taken together these observations imply the presence of an extraordinarily large 
number of alloreactive cells in the T-cell population (9). This apparent commitment 
ofT cells to specificites expressed by polymorphic variants of the MHC (alloreactivity) 
has puzzled immunologists, because of the apparent biologic irrelevance of immunity 
to foreign MHC products. One explanation for this high level of alloreactive cells and 
for the strong allogeneic response elicited without prior in vivo priming is based upon 
the recent evidence that  T  cells may recognize foreign antigens in association with 
autologous MHC gene products on the surface of cells (10). Alloreactivity, may thus 
reflect  a  high  degree  of cross-reactivity  of T-cell  receptors  for  autologous  MHC 
products associated with antigen, and polymorphic variants of MHC gene products 
within  the  species  (alloantigens)  (11,  12). According  to  this  view  alloreactive  T 
memory cells may be continuously generated after stimulation by autologous MHC 
* Supported by U. S. Public Health Service grants CA-14723, AI-13600, and AI-12184. 
Present address:  Centre d'Immunologie, Institut National de la Sant~ et de la R~cherche Medicale- 
Centre National de la R6cherche Scientifique Marseille,  France. 
§ Scholar of the Leukemia Society of America. 
l Abbreviations  used in this paper." B6-S, B6-Sendai;  C, complement; CTL, cytolytic T  lymphocyte; E: T, 
effector:  target ratio;  FCS,  fetal  calf serum;  LN, lymph node, LPS, lipopolysaccharide;  MEM, Eagle's 
minimal essential medium; MHC, major histocompatibility complex; NMS, normal mouse serum;  TNP, 
trinitrophenyl. 
1414  J. Exp. M~D. © The Rockefeller University Press • 0022-1007/78/1101-141451.00 
Volume 148  November 1978  1414-1422 BURAKOFF  ET AL.  1415 
products associated with antigen, such as a  virus. This view is consistent  with earlier 
findings that alloreactive CTL specifically lyse autologous cells coupled with trinitro- 
phenyl (TNP)  molecules (11). 
One approach to this question involves a comparative analysis of the cellular basis 
for the  CTL  response  after  stimulation  by modified  autologous  MHC  products  or 
allogeneic MHC products.  Preliminary experiments have indicated that cells bearing 
the Ly123 phenotype (which arise earliest in ontogeny [3]) give rise to Ly23 cytotoxic 
cells after stimulation  in vitro by chemically modified autologous cells  (13), whereas 
cells of the  Ly23 set  respond  to alloantigens  (3).  These  findings  raise  the  following 
question: does continuous in vivo stimulation  of clones of Ly123 cells by autologous 
MHC  products that have been modified in vivo (by viruses or other agents)  result in 
the formation of the Ly23 memory pool, which can be restimulated  by polymorphic 
variants of MHC  antigens? 
The experiments  reported  here and elsewhere  (18)  indicate  that  alloreactivity  (as 
manifest  in  the  CTL  response)  may result  from  continuous  in  vivo stimulation  of 
Ly123 cells reactive to autologous cells  that  appear  foreign because  they have been 
modified  by association  with  non-MHC  antigens  (such  as  virus);  such  stimulation 
results  in  the  generation  of Ly23  +  memory  progeny  which  specifically  lyse  cells 
bearing MHC  products that are foreign by virtue of genetic polymorphisms  (alloan- 
tigens). 
Materials  and Methods 
Mice.  6-  to  12-week-old  male or female mice of the following strains:  C57BL/6  (H-2b), 
DBA/2 (H-2d), and B 10.D2 (H-2  d) were purchased from The Jackson Laboratory, Bar Harbor, 
Maine. B6D2Fx (H-2  b/a) mice were purchased from Cumberland View Farms (Clinton, Tenn.). 
Young B6 mice were bred at Harvard Medical School, Boston, Mass.,  by Dr. Charles Sidman. 
B6-Ly2.1  congenic mice were bred at the Sloan Kettering Institute,  New York, by Dr. E.  A. 
Boyse. 
Tumors.  P815  (H-2  a)  mastocytoma was maintained  in  DBA/2 mice and  the EL4 (H-2  ~) 
leukemia was maintained  in B6 mice. These tumors were carried  in ascites  form by weekly 
intraperitoneal transfer. 
Antisera.  For details of the preparation and use of antisera to Lyl.2, Ly2.2, and Ly3.2, see 
Shen et al.  (14). 
Isolation ofLy  + T-Cell Sets.  Before in vitro stimulation, 20- 50 ×  106/ml normal lymph node 
(LN) cells or spleen cells were incubated with Lyl.2 antiserum, or Ly2.2 plus 3.2 antiserum, or 
normal  mouse serum  (NMS)  at  a  final  dilution  of 1:40  to  1:60  in  balanced  salt  solution 
supplemented  with  10% fetal  bovine serum  for 40 rain at  room temperature.  After washing 
once, the cells were resuspended in  1 ml of freshly thawed selected rabbit serum (diluted  1:10 
to 1:20 in phosphate-buffered saline)  as a source of complement (C), and were incubated for an 
additional 30 rain at 37°C. 
After in vitro stimulation, effector (CTL), LN, or spleen cells were incubated with Ly sera 
+  C  as  stipulated  above;  this  procedure  was  repeated  to  ensure  optimal  specific  lysis,  as 
described previously (15). 
Generation of CTL.  5 ×  10  n lymph node or spleen cells were incubated at 37°C with 5 ×  10  n 
irradiated  (1,200 rads, General  Electric Maximar 250-III, General  Electric Co., Wilmington, 
Mass.)  allogeneic or TNP-modified syngeneie spleen cells in 2 ml  ×  5 days in  16-ram  tissue 
culture wells  (Linbro Chemical Co., New Haven, Conn.) in a humidified atmosphere of 95% 
air  and  5%  CO2.  Cell  culture  medium  consisted  of RPMI-1640,  ~enicillin  (100  U/ml), 
streptomycin (100/~l/ml)  supplemented with 2 mM glutamine, 5 ×  10-  M 2-mercaptoethanol 
and  10%  heat-inactivated  fetal  calf serum  (Microbiological  Associates,  Walkersville,  Md.). 
Erythrocytes  were  removed  from  stimulator  cells  by  a  0.5-rain  incubation  in  Tris- 
HCl/ammonium chloride. 
CTL were induced  to Sendai  virus-modified autologous cells  using a  protocol similar  to 1416  ALLOREACTIVITY  AND  T-CELL  SETS 
TABLE  I 
Ly Phenotype of Precursor and Effector CTL Stimulated by Alloantigens that Lyse both Allogeneic and Modified 
Syngeneic Targets 
Exp.  Stimulator 
Sensitization phase:*  Effector phase::~ 
Responder T-ceil set sensitized  T-cell sets: 
Target  E:T 
l,y[  + 
Unselected  Lyl  Ly23  Exp.  E:T  Unselected  Lyl  Ly23 
Ly23 
l  1)BA/2(H-2  d )  PBI5(H-2  d)  2.5:1  21§  9  51  25  111  10:1  13  0  16 
EL-4-TNP  50:1  35  9  62  27  40: [  25  t)  33 
(H-2 h) 
II  I)BA/2  PBI5  10:l  34  0  51  39 
EL-4-TNP  40:1  49  0  53  23 
* 5  ×  106 B6 cells of the indicated T-cell set were stimulated with allogeneic DBA/2(H-2 a) spleen cells; Lyl cells were obtained after treatment of B6 
LN cells with Ly2.2 and Ly3.2 antisera +  C, and I,y23 cells were obtained after treatment of B6 LN cells with Ly 1.2 antisera +  C: 1Jy I  +  Ly23 cells 
represent  I : 1 mixtures of the two cell populations.  See Materials and Methods for details of treatment and culture conditions. 
After stimulation of B6 unselected LN cells by DBA/2 spleen cells for 5 days, the remaining cells were treated with NMS or the relevant I,y serum 
+  C  (see Materials and Metht~ds  for details of procedure)  to produce the indicated T-cell sets, 
§ Values are percent specific release of ~tCr against the indicated target cell, Spontaneous  release of P815 ranged between  10 and  12%, and EL-4-TNP 
ranged between  11 and 32%, Minimal lysis of EL-4 target cells was noted, 
Schrader and Edelman (16): 7 ×  106 spleen cells were co¢ultured with 6  ×  10  n X-irradiated 
stimulator spleen cells that had been incubated with ,8-propriolactone-inactivated  Sendal virus 
(Connaught Laboratories, Willowdale, Ontario). Stimulator cells were prepared by incubating 
50  ×  10  e X-irradiated spleen cells and 0.01 ml of/~-propriolactone-inactivated  Sendal virus in 
2 ml of Eagle's minimal essential medium (MEM)-10% fetal calf serum (FCS)  for 90 min at 
37°C. These cells were washed three times before use. 
Assay of CTL.  The SlCr release assay has been described in detail (17). Briefly, targets were 
labeled by incubation  with Na ~1CrO4. Lipopolysaccharide (LPS)-stimulated  spleen cells (>90% 
blast cells)  were  used as  a  source of target  cells  as  described previously (11). Sendal virus 
6  51  modified target  cells were prepared by incubation of 3  ×  10  Cr-labeled LPS-stimulated 
spleen cells with 0.01 ml fl-propriolactone-inactivated  Sendal virus in 2 ml MEM-10% FCS for 
90 rain at 37°C. These cells were washed three times before use. 
0.1  ml of a cell suspension containing 104 labeled targets in supplemented MEM (17) was 
added to  10  ×  75  mm round bottom glass tubes containing 0.1  ml of varying numbers of 
effector  cells or normal cells. These cultures were  incubated for 4 h  at 37°C in 83% N2,  10% 
CO2, and 7% 02 on a rocking platform. 1 ml of phosphate-buffered saline was added to each 
tube before centrifugation; supernates were removed and assayed to determine isotope release. 
All measurements were performed in duplicate or triplicate and the standard error of the mean 
was always <2-3%. Percent specific release was calculated as (E-C)/FT-C)  ×  100%, where E 
=-  isotope  release  from tubes containing immune effectors  plus targets, C  =  isotope release 
from  tubes  containing normal  spleen  cells  plus  targets  (spontaneous release)  and  FT  -- 
maximum isotope release determined after four cycles of freezing and thawing target cells. 
Notations.  Unless otherwise indicated, Lyl  cells signifies  cells  treated with anti-Ly2.2  + 
anti-Ly3.2 +C; Ly23 cells signifies cells treated with anti-Lyl.2 +  C; and unselected T  cells 
signifies cells treated with NMS  +  C, according to the protocols stipulated above. For brevity, 
whenever pretreatment of a cell population is referred to, it is implied that this took place in 
the presence of complement. 
Results 
T-Cell Sets Responsible for Generation of Alloreactive  and Cross-reactive CTL after Stimulation 
by Allogeneic  Cells  (Table I).  The in vitro (4)  and in vivo  2 generation of Ly23 CTL 
requires Ly 1 help. However, stimulation of large numbers of Ly23 cells in the absence 
of Ly1 cells results in efficient generation of Ly23  + CTL, if selected lots of fetal calf 
sera are used. 
2 B. Huber,  and  H.  Cantor.  Manuscript  submitted  for publication. BURAKOFF  ET  AL.  1417 
TABLE  II 
Demonstration that Cells of the Ly123 Set are Precursors  of Ly23 CTL after Stimulation by TNP- 
Modified Syngeneic Cells* 
Donor of re- 
sponder cell 
Sensitization phase: 





% lysis (10:1  E:T) after treatment 
of MLC-activated cells with:~ 
T-cell set selected  NMS  Anti-Ly2.1  Anti-Ly2.2 
A B6  NMS  All (3  ×  10  s)  24  29  2 
B B6-Ly2.1,3.2  Anti-Lyl.2  Ly23 (3  ×  106)  0  ND§  ND 
C  A(3  X  l0  s )  +  B(3  x  106  )  29  33  3 
D B6-Ly2.1,3.2  NMS  All (3  x  l0  s)  19  4  21 
E B6  Anti-Lyl.2  Ly23 (3  X  106)  0  ND  ND 
F  D(3  X  l0  s )  +  E(3  x  106 )  21  5  25 
* See text for explanation of protocol. 
Background (spontaneous  5~Cr release) was less than 10%. 
§ ND, not done. 
Stimulation of B6  (H-2  b)  Ly23 cells with irradiated DBA/2  (H-2  d) cells in vitro 
results in the formation of Ly23 progeny that lyse both P815  (H-2  d) and EL-4-TNP 
(H-2b-TNP).  Lysis of the  latter  cells  has  been  shown  to  be  specific, because  it  is 
inhibited with cold nonradiolabeted P815  or EL-4-TNP but not EL-4 targets  (10). 
We conclude that activation of Ly23 prekiller cells by allogeneic cells results in the 
formation  of Ly23  CTL  that  lyse  both  allogeneic  targets  as  well  as  chemically 
modified autologous targets. 
T-Cell  Sets  Responsible for  Generation of CTL  after  Stimulation  by  Chemically-Modified 
Syngeneic Cells (Table II).  B6 cells were stimulated by TNP-coupled syngeneic cells; 
cytolytic activity was  assessed  against  TNP-coupled  syngeneic target  cells  (EL-4- 
TNP).  Ly123 cells are  required  for the  generation of Ly23 CTL that  lyse TNP- 
coupled syngeneic target cells (13). 
The requirement  for Ly123 cells indicates that  (a)  Ly123 cells are precursors of 
Ly23 killer effector cells or  (b)  Ly123 cells help Ly23 precursors to differentiate to 
Ly23 killer-effector cells. The following experiments support the first interpretation: 
B6  mice  (Ly phenotype  1.2, 2.2,  3.2) were  used  as  a  source  of Ly123 cells  (after 
treatment with NMS); B6-Ly2.1 congenic mice (Ly phenotype 1.2, 2.1, 3.2) were used 
as the source of Ly23 cells (after treatment with anti-Ly  1.2). In a  1:1 mixture of these 
two preparations any Ly23 killer effector cells that derived from Ly23 prekiller cells 
would be marked by the Ly2.1 antigen. Cytotoxic effector activity generated by this 
cell mixture was virtually abolished by treatment with anti-Ly2.2, and completely 
resistant to treatment with anti-Ly2.1  (Table  II).  Similar conclusions were drawn 
from experiments in which cells from B6-Ly2.1 congenic mice were used as the source 
of Ly123 cells and cells from B6 mice were used as the source of Ly23 cells. 
The above findings, taken together, indicate that in adult mice, prekiller activity to 
TNP-coupled cells and to allogeneic cells reside in different T-cell sets: Ly23 cytotoxic 
effector cells generated after stimulation by TNP-coupled autologous cells are drawn 
from the  Ly123 precursor pool, while Ly23 cytotoxic effector cells generated after 
stimulation by allogeneic cells arise almost entirely from Ly23 precursor cells. Ly23  + 1418  ALLOREACTIVITY AND T-CELL SETS 
TABLr III 
Ontogeny of Alloreactive T-Cell Sets 
Treatment of pre-  T-cell set se- 
killer cell*  lected 
Weeks after birth (% lysis) 
1-1/2~  3~  5§  12§ 
NMS  Unselected  16  28  43  59 
Anti-Lyl (A)  Ly23  2  15  38  63 
Anti-Ly23 (B)  Ly I  0  1  3  6 
(A) +  (B) (1:1)  Lyl +  Ly23  0  4  36  55 
* B6 spleen +  LN cells were treated with the indicated sera just before addition to 
cultures containing irradiated (2,000 rads) BALB/c spleen cells. Cytolytic activity 
(percent lysis) of cells from 1-1/2 and 3-wk-old donors against P8 l 5 target cells was 
measured 5 days later. 
:]: E:T ~  40:1 
§ E:T ffi 10:1 
cytolytic  effector cells  stimulated  by alloantigens  exhibit  a  high  degree of lysis of 
TNP-coupled autologous (and allogeneic) targets. 
These  considerations  are  consistent  with  the  notion  that  clones  of Ly123  cells 
bearing receptors for variants of autologous MHC products (such as those formed by 
virus associated with self MHC products)  give rise to Ly23 memory cells which can 
also react  to polymorphic variants of the  MHC  (alloantigens).  This  interpretation 
suggests two predictions:  (a) early in ontogeny, alloreactive prekiller cells arise from 
the  Ly123  and  not  the  Ly23  pool  and  (b)  stimulation  of T  cells  in  vitro by virus 
infected autologous cells should result in the generation of Ly23  + CTL that specifically 
lyse noninfected allogeneic target cells. The following experiments were designed to 
test these predictions. 
T-Cell  Sets  Responsible for  Alloreactive Prekiller Activity  During  Ontogeny (Tables  III, 
IV).  We examined the Ly phenotype of alloreactive prekiller cells in the spleens of 
donors at increasing intervals after birth (Table III). Spleen cells from 2-week-old B6 
mice generate Ly23 eytolytie effeetor cells after stimulation with DBA/2 (H-2  a) spleen 
cells  (Table IV).  Ly123 cells are required  for generation  of Ly23 alloreactive killer 
cells, because  1:1  mixtures of Lyl  +  Ly23 cells  (Le.,  anti-Lyl  treated cells  +  anti- 
Ly23 treated cells) did not generate significant lytic activity. 
These findings  indicate  that  the phenotype of alloreactive prekiller cells at  1 wk 
after  birth  is  Lyl+2+3  ÷.  Examination  of  the  Ly  phenotype  of  prekiller  cells  of 
progressively older mice revealed that a substantial portion of prekiller activity resides 
in the Ly123 set 3 wk after birth but that by 5 wk after birth virtually all alloreactive 
prekiller activity was invested in cells of the Ly23 set (Table III). 
Stimulation of B6 Cells by Sendai-Modified B6 Spleen Cells Results in the Generation of CTL 
Specific  for Both B6-Sendai Target Cells and Unmodified A llogeneic Target Cells (Table I1).  B6 
spleen cells were stimulated for 5 days by B6 cells coated with chemically-inactivated 
Sendai  virus  (B6-S).  Such  stimulation  resulted  in the generation of CTL that  lysed 
B6-Sendai coated target cells but not (uncoated) syngeneic B6 target cells (Table V). 
In addition, the same CTL exerted substantial lytic effects on B 10.BR target cells. A 
detailed evaluation of the specificity of the latter lysis by cold target inhibition clearly 
demonstrates that  these  alloreactive CTL also bear receptors  for B6-Sendai  coated 
cells: the lysis of B 10.BR nlCr labeled targets was inhibited by the addition of B 10.BR BURAKOFF  ET  AL. 
TABLE IV 
Ly Phenotype of Alloreactive Cytolytic T-Cells in Neonatal and Adult Life* 
Treatment of B6 CTL:~  T-cells selected 
Age of donor 
(weeks after birth) 
% lysis 
2 wk  8 wk 
NMS  All  55  54 
Anti-Ly I  Ly23  43  48 
Anti-Ly23  Ly 1  9  2 
* B6  spleen  cells were  stimulated  with  DBA/2  irradiated  spleen  cells and 
assayed on  P815  targets at  an  E:T  ratio  of 2.2/1.  Values are  in  percent 
specific release of 51Cr. 
:]: NMS is CTL treated with NMS  +  C; anti-Lyl is CTL treated with Lyl.2 
antiserum  +  C;  anti-Ly2  +  3  is  CTL  treated  with  Ly2,2  and  Ly3.2 
antiserum +  C. 
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or B 10-Sendai coated cold targets but not significantly inhibited by B 10 or B 10-TNP 
cold targets (18). 
The Ly phenotype of prekiller and killer-effeetor cells responsible for lysis of Sendai- 
modified autologous cells  was  determined.  CTL  activity against  both  autologous 
Sendai-modified and unmodified allogeneic target cells was invariably mediated by 
Ly23 cells.  Prekiller activity resided  mainly in  Ly123 T-cells  (Table  V),  but  was 
occasionally observed in Ly23 cells (data not shown). 
Discussion 
These studies were undertaken to determine the cellular basis of reactivity against 
lymphocytes carrying MHC components that are foreign by virtue of polymorphism 
(alloantigens)  or  because  of modification by  chemicals  or  viruses  (TNP-modified 
autologous lymphocytes). The results reported here can be summarized as follows: (a) 
exposure  of Ly23 cells  from  adult  mice  to  allogeneic  cells  in  vitro  results  in  the 
formation of Ly23  + effector cells  that  lyse appropriate  allogeneic and  chemically 
modified syngeneic target cells. 
(b)  Exposure of Ly123 cells from adult  mice to chemically-modified autologous 
cells in  vitro stimulates the  development of Ly23  + effector cell  progeny that  lyse 
modified-autologous cells, a 
(c) Studies of the ontogeny of the T-cell sets responsible for generating alloreactive 
cytolytic activity indicate that early after birth (1-3 wk) alloreactive CTL are derived 
from Ly123 precursors cells.  However, at approximately 3-5 wk of age, alloreactive 
prekiller activity shifts from the Ly123 compartment to the Ly23 compartment. 
(d) Exposure of Ly  123 T cells to autologous cells modified by chemically inactivated 
Sendai virus stimulates the generation of Ly23  + CTL clones that lyse both syngeneic 
virus-coated targets (B6-S)  as well as noninfected allogeneic targets. This latter lysis 
reflects CTL clones that recognize B6-S antigens (18). 
Based on these results we propose  the following explanation for the alloreactive 
a It should be noted, too, that this antigen stimulated Ly123---.23  differentiation step is also responsible 
for the generation of cytotoxic effeetor cells against MuLV  + syngeneic lymphoma cells in B6 mice (J. C. 
LeCIerc et al. Manuscript in preparation), and is probably responsible for the generation of CTL against 
syngeneic mammary tumor cells (19). 1420  ALLOREACTIVITY AND T-CELL SETS 
TABLE g 
Ly Phenotype of Precursors and Effector CTL Stimulated by Sendal Modified Syngeneic Antigens 
that Lyse Modified Syngeneic and Unmodified Allogeneic Targets 
CTL  Target 
Sensitization phase* 
Responder T-cell set sensitized 
E:T 
Unselected  Lyl  Ly23  Lyl +  Ly23(l:l) 
B6 Anti-B6-S  B6-S  11 : 1  73~  8 
BI0.BR  100:1  33  4 
Effector phase§ 
CTL  Target  E:T 
Unselected 
B6D2FI Anti-B6D2FrS  B6D2FrS  100:1  70 b 
BI0.RIII  100: t  34 
10  5 
5  ND 
T-cell Set 
Lyl  Ly23 
16  60 
6  29 
* 5 x  106 B6 cells of the indicated T-cell set were stimulated with Sendal coated syngeneic spleen 
cells; Lyl cells were obtained after treatment  of B6 LN cells with Ly2.2 and Ly3.2 antisera  +  C, 
and Ly23 cells were obtained after treatment  of B6 LN cells with Lyl.2 antisera  +  C; Lyl  + 
Ly23 cells represent  1:1  mixtures of the two cell populations.  See Materials and Methods  for 
details of treatment and culture conditions. 
~: Values represent percent specific SlCr release against the indicated target cells (LPS-stimulated 
spleen cells). 
§ After stimulation  of B6D2FI spleen cells by Sendal coated B6D2Fj spleen cells for 5 days, the 
remaining cells were treated with NMS or the relevant Ly serum + C (see Materials and Methods 
for details of procedure) to produce the indicated T-cell sets. Percent lysis produced in a 4-h assay 
against the indicated target cell at a 100:1 E:T ratio is shown. 
response of adult  mice:  continuous  stimulation of Ly123  cells by autologous MHC 
structures  associated  with  foreign  material  (e.g.  virus)  results  in  the  formation  of 
populations of Ly23 memory cells carrying receptors that bind to MHC  products that 
are foreign due to genetic polymorphism (alloantigens). This view is supported most 
directly by two findings: (a) in vitro stimulation ofT cells by autologous, virus-coated 
cells results in the formation of Ly23  + CTL that specifically iyse both syngeneic virus- 
infected target cells as well as uninfected allogeneic cells, and  (b)  early in ontogeny, 
prekiller activity  for  both  TNP-coupled  syngeneic  and  allogeneic  MHC  products 
resides in the same  (Ly123 +) T-cell pool; later in ontogeny, alloreactivity is invested 
in  Ly23  cells  which,  when  activated,  can  lyse  both  allogeneic  and  TNP-coupled 
syngeneic target cells, 
Several direct experimental predictions can be inferred from this view of alloreac- 
tivity:  (a)  natural  exposure  of mice  to  Sendal  virus  should  preferentially enhance 
Ly23  reactivity to allogeneic cells (evidence  for this  is provided elsewhere  (18)  and 
tolerogenic exposure to Sendal virus might selectively diminish reactivity to allogeneic 
cells expressing highly cross-reactive MHC  haplotypes;  (b)  At  some  time  after  im- 
munization  with  Sendal  virus  in  vivo,  Ly23  cells should  contain  prekiller activity 
against both Sendal coated syngeneic targets and allogeneic targets after boosting in 
vitro with Sendal coated syngeneic cells. (c) Increased immunogenic exposure to virus- 
associated antigens (e.g. in the NZB mouse strain) early in ontogeny should accelerate 
the development and/or  increase the proportion of Ly23-mediated alloreactive pre- 
killer activity; (a  t) stimulation of T  cells by pooled irradiated cells expressing all the 
MHC  haplotypes of the species may be expected to  generate efficient CTL  against BURAKOFF ET AL.  1421 
(a)  autologous target  cells  infected by a  large  variety of viruses,  and  (b)  perhaps 
certain autologous tumor cells. Such CTL activity should be inhibited by both pooled 
allogeneic and virus-infected autologous cold target cells. 
Recent experiments have indicated that MHC products exert important selective 
effects during T-cell differentiation in the thymus (20). The present studies indicate 
that post-thymic differentiation steps also may be driven by antigen in relationship 
with host MHC products: TL-Ly123  + cells may be stimulated by foreign materials 
associated with self MHC-products to generate Ly23 progeny that are  marked by 
their ability to lyse allogeneic cells. 
The phenomenon of alloreactivity is not limited to the generation of CTL. Dispro- 
portionately large numbers of T  cells also respond to alloantigens in MLC of mouse 
(21), rat (8), and human (22) cells. This reaction is mainly a measure of proliferating 
cells,  and,  in  the  presence  of a  complete  I-region  disparity,  primarily  reflects the 
contribution of Lyl cells  (3).  It will be  important  to  determine whether a  similar 
Ly123--*Lyl differentiation step accounts for this form of alloreactivity. If this is the 
case, the phenomenon of alloreactivity which heretofore appeared to lack evolutionary 
significance  may  begin  to  make  sense  in  the  context  of immunological  defense 
mechanisms. 
Summary 
We  have  analyzed  the  cellular  basis  of T-cell  reactivity  against  lymphocytes 
expressing major histocompatibility complex  (MHC)  products that  are  foreign by 
virtue of polymorphism  (alloantigens)  or because  of modification by chemicals or 
viruses. We find that early in ontogeny, prekiller activity against both trinitrophenyl 
(TNP)-coupled autologous MHC products and allogeneic MHC products resides in 
the same  (Ly123  +) T-cell pool;  later in ontogeny alloreactivity is invested in Ly23 
cells which, when activated, lyse TNP-coupled autologous cells as well as appropriate 
allogeneic target cells. We demonstrate that stimulation of Ly123  + T  cells in vitro by 
autologous cells coated with chemically-inactivated Sendai virus results in the for- 
mation of Ly23  + cytolytic T  lymphocytes (CTL)  that  specifically lyse both  virus 
modified autologous target cells and unmodified allogeneic target cells. 
These  results  suggest  the  following model  to  account  for the  presence  of large 
numbers  of alloreactive T-cell  clones  in  adult  animals:  continuous stimulation of 
Ly123 cells by autologous MHC antigens associated with foreign materials such as a 
virus  results  in  the  formation  of Ly23  memory  progeny  carrying  receptors  that 
recognize MHC products that are foreign due to genetic polymorphism (alloantigens). 
In general, these studies indicate that alloaggression (as manifest by Ly23 cells in the 
CTL response)  reflects a  high degree of cross  stimulation between physiologically 
relevant antigens, e.g., viral determinants associated with self MHC products, and 
biologically irrelevant allelic variants of the MHC. 
We thank Sheldon Ratnofsky, Laila McVay-Bourdreau,  and Joan Hugenberger  for excellent 
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